Quantum Cyber NV (QUCY)

NASD · Healthcare · Diagnostics & Research · USA

Quantum Cyber NV is a micro cap company (market value under $300 million) in the Diagnostics & Research industry.

Quantum Cyber NV develops in-vitro diagnostic tests for cancer detection. The company is commercializing a blood-based pancreatic cancer screening test using mRNA biomarkers and proprietary algorithms, and is developing PancAlert, a stool-based pancreatic cancer screening test. It previously marketed ColoAlert, a colorectal cancer screening test in European markets, but has wound down this product.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Quantum Cyber NV stock.

Our verdict on QUCY

Not valued: We cannot value this company yet.

Browse

Peers in Diagnostics & Research

All 44 Diagnostics & Research stocks

Cheaper than QUCY in Diagnostics & Research

23 more in this industry show a wider margin of safety.

Is QUCY undervalued or overvalued?

We do not publish a verdict on QUCY yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of QUCY?

We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.